VYE-21643-43065
2 vaccinations
2 coded responses
22 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 606 / IL
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-02
Registered in v-safe
-
2021-02-02
Dose 1 — Pfizer-BioNTech
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-06
- 2021-02-07
- 2021-02-09
- 2021-02-16
-
2021-02-23
Dose 2 — Pfizer-BioNTech
- 2021-02-23
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-25
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-11
-
2021-03-16
Survey response — day 21, dose 2MedDRA: Diarrhoea, Gastroenteritis viral, Headache, Nausea, Vomiting — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Viral gastroenteritis: nausea, vomiting, diarrhea, headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-25
- 2021-03-30
- 2021-04-06
- 2021-05-27
- 2021-08-24
-
2022-02-23
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-23
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Pfizer-BioNTech | |
| 2 | 2021-02-23 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-16 | Unsuccessful | |
| 2022-02-23 | Unsuccessful |
Free text
Release 5 — day 21, dose 2
Symptoms: Viral gastroenteritis: nausea, vomiting, diarrhea, headache
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Gastroenteritis viral | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release